In vivo pharmacokinetics of aldose reductase inhibitors: 3-fluoro-3-deoxy-D-glucose NMR studies in rat brains.

Ingrid Kwee, T. Nakada

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Direct quantification of the inhibitory effects of orally administered drugs (sorbinil, cyclandelate and sulindac) on aldose reductase activities in rat brains was performed non-invasively using the 3-fluoro-3-deoxy-D-glucose (3-FDG) 19F NMR spectroscopic technique. Quantitative data obtained directly from the target organ (brain) allowed for unprecedentedly accurate analysis of drug effects in the brain in vivo. Sorbinil, a potent aldose reductase inhibitor, exhibited a classic monophasic organ response, whereas cyclandelate and sulindac showed biphasic suppression patterns. The latter indicate that there are metabolites of these drugs which possess aldose reductase inhibitory activities. The estimated potency of aldose reductase inhibition for each of the three drugs in this study was significantly discrepant from the in vitro studies indicating the complicated nature of the bioavailability of a pharmaceutical agent in vivo, especially where pharmacologically active metabolites of a given drug are involved. Our method allows for a direct quantitative assay and hence the most reliable technique for evaluating aldose reductase inhibitory activities in the target organ.

Original languageEnglish (US)
Pages (from-to)44-46
Number of pages3
JournalNMR in Biomedicine
Volume2
Issue number1
StatePublished - Jun 1989

Fingerprint

Aldehyde Reductase
Pharmacokinetics
Rats
Brain
Nuclear magnetic resonance
Cyclandelate
Pharmaceutical Preparations
Sulindac
Metabolites
Biological Availability
3-deoxy-3-fluoro-D-glucose
Assays

ASJC Scopus subject areas

  • Biophysics

Cite this

In vivo pharmacokinetics of aldose reductase inhibitors : 3-fluoro-3-deoxy-D-glucose NMR studies in rat brains. / Kwee, Ingrid; Nakada, T.

In: NMR in Biomedicine, Vol. 2, No. 1, 06.1989, p. 44-46.

Research output: Contribution to journalArticle

@article{a2fce0608c38466ea2939db6c8fc430d,
title = "In vivo pharmacokinetics of aldose reductase inhibitors: 3-fluoro-3-deoxy-D-glucose NMR studies in rat brains.",
abstract = "Direct quantification of the inhibitory effects of orally administered drugs (sorbinil, cyclandelate and sulindac) on aldose reductase activities in rat brains was performed non-invasively using the 3-fluoro-3-deoxy-D-glucose (3-FDG) 19F NMR spectroscopic technique. Quantitative data obtained directly from the target organ (brain) allowed for unprecedentedly accurate analysis of drug effects in the brain in vivo. Sorbinil, a potent aldose reductase inhibitor, exhibited a classic monophasic organ response, whereas cyclandelate and sulindac showed biphasic suppression patterns. The latter indicate that there are metabolites of these drugs which possess aldose reductase inhibitory activities. The estimated potency of aldose reductase inhibition for each of the three drugs in this study was significantly discrepant from the in vitro studies indicating the complicated nature of the bioavailability of a pharmaceutical agent in vivo, especially where pharmacologically active metabolites of a given drug are involved. Our method allows for a direct quantitative assay and hence the most reliable technique for evaluating aldose reductase inhibitory activities in the target organ.",
author = "Ingrid Kwee and T. Nakada",
year = "1989",
month = "6",
language = "English (US)",
volume = "2",
pages = "44--46",
journal = "NMR in Biomedicine",
issn = "0952-3480",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - In vivo pharmacokinetics of aldose reductase inhibitors

T2 - 3-fluoro-3-deoxy-D-glucose NMR studies in rat brains.

AU - Kwee, Ingrid

AU - Nakada, T.

PY - 1989/6

Y1 - 1989/6

N2 - Direct quantification of the inhibitory effects of orally administered drugs (sorbinil, cyclandelate and sulindac) on aldose reductase activities in rat brains was performed non-invasively using the 3-fluoro-3-deoxy-D-glucose (3-FDG) 19F NMR spectroscopic technique. Quantitative data obtained directly from the target organ (brain) allowed for unprecedentedly accurate analysis of drug effects in the brain in vivo. Sorbinil, a potent aldose reductase inhibitor, exhibited a classic monophasic organ response, whereas cyclandelate and sulindac showed biphasic suppression patterns. The latter indicate that there are metabolites of these drugs which possess aldose reductase inhibitory activities. The estimated potency of aldose reductase inhibition for each of the three drugs in this study was significantly discrepant from the in vitro studies indicating the complicated nature of the bioavailability of a pharmaceutical agent in vivo, especially where pharmacologically active metabolites of a given drug are involved. Our method allows for a direct quantitative assay and hence the most reliable technique for evaluating aldose reductase inhibitory activities in the target organ.

AB - Direct quantification of the inhibitory effects of orally administered drugs (sorbinil, cyclandelate and sulindac) on aldose reductase activities in rat brains was performed non-invasively using the 3-fluoro-3-deoxy-D-glucose (3-FDG) 19F NMR spectroscopic technique. Quantitative data obtained directly from the target organ (brain) allowed for unprecedentedly accurate analysis of drug effects in the brain in vivo. Sorbinil, a potent aldose reductase inhibitor, exhibited a classic monophasic organ response, whereas cyclandelate and sulindac showed biphasic suppression patterns. The latter indicate that there are metabolites of these drugs which possess aldose reductase inhibitory activities. The estimated potency of aldose reductase inhibition for each of the three drugs in this study was significantly discrepant from the in vitro studies indicating the complicated nature of the bioavailability of a pharmaceutical agent in vivo, especially where pharmacologically active metabolites of a given drug are involved. Our method allows for a direct quantitative assay and hence the most reliable technique for evaluating aldose reductase inhibitory activities in the target organ.

UR - http://www.scopus.com/inward/record.url?scp=0024679262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024679262&partnerID=8YFLogxK

M3 - Article

C2 - 2518153

AN - SCOPUS:0024679262

VL - 2

SP - 44

EP - 46

JO - NMR in Biomedicine

JF - NMR in Biomedicine

SN - 0952-3480

IS - 1

ER -